๐Ÿ•ต๏ธ ENZO Biochem Inc ($ENZB)

SEC insider & ownership activity, last 12 months ยท CIK 316253 ยท every row links its SEC filing

Insiders were quiet over the last 12 months โ€“ no open-market buys or sells. One red-flag 8-K in the window: Delisting notice (3.01), Aug 20, 2025.

Insider flow

0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)

No open-market insider transactions in the last 12 months.

5%+ holders

HolderStakeClassScheduleEvent
Battery Partners XIV, L.P. 21.8% 13DJun 23, 2025 filing โ†—
Battery Partners GP XIV, LLC 21.8% 13DJun 23, 2025 filing โ†—
Zachary Smotherman 21.8% 13DJun 23, 2025 filing โ†—
Neeraj Agrawal 21.8% 13DJun 23, 2025 filing โ†—
Michael M. Brown 21.8% 13DJun 23, 2025 filing โ†—
Russell L. Fleischer 21.8% 13DJun 23, 2025 filing โ†—
Jesse Feldman 21.8% 13DJun 23, 2025 filing โ†—
Morad Elhafed 21.8% 13DJun 23, 2025 filing โ†—
Roger H. Lee 21.8% 13DJun 23, 2025 filing โ†—
Chelsea R. Stoner 21.8% 13DJun 23, 2025 filing โ†—
Dharmesh Thakker 21.8% 13DJun 23, 2025 filing โ†—
Battery Ventures XIV, L.P. 21.8% 13DJun 23, 2025 filing โ†—
Battery Ventures Xiv-Ef, L.P. 21.8% 13DJun 23, 2025 filing โ†—
Battery Investment Partners XIV, L.P. 21.8% 13DJun 23, 2025 filing โ†—
Jack Bryant 9.9% 13DJun 23, 2025 filing โ†—
Kenan Lucas 9.9% 13DJun 23, 2025 filing โ†—
Raymond Harbert 9.9% 13DJun 23, 2025 filing โ†—
Harbert Fund Advisors, Inc. 9.9% 13DJun 23, 2025 filing โ†—
Harbert Management Corporation 9.9% 13DJun 23, 2025 filing โ†—
Harbert Discovery Co-Investment Fund I, LP 6.5% 13DJun 23, 2025 filing โ†—
Harbert Discovery Co-Investment Fund I GP, LLC 6.5% 13DJun 23, 2025 filing โ†—

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Acquisition or disposition (2.01)Aug 20, 2025 filing โ†—
Delisting notice (3.01)Aug 20, 2025 filing โ†—
Material Modifications to Rights of Security Holders (3.03)Aug 20, 2025 filing โ†—
Change of control (5.01)Aug 20, 2025 filing โ†—
Officer/director changes (5.02)Aug 20, 2025 filing โ†—
Charter/bylaw changes (5.03)Aug 20, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Aug 20, 2025 filing โ†—
Shareholder vote (5.07)Aug 19, 2025 filing โ†—